Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
tanezumab (1 trial)
Cancer Pain (Phase 3)
Musculoskeletal Pain (Phase 3)
Neoplasm Metastasis (Phase 3)
Trials (1 total)
Trial APIs (1 total)